Pharmacogenomics Panel

Pharmacogenomics Panel

Designed to help individuals understand how their genetics may lead to medication success or side effects around actionable medications as identified by the FDA.

BENEFITS:

• Eliminates the need for trial and error by eliminating the need for using generalized guidelines for drug choice and dosing and allowing individualized drug regimen.
• Decreases the risk of adverse drug reactions by ensuring the right dosage for each individual.
• Decreases overall cost of healthcare by decreasing the amount of drug toxicity and increasing drug efficacy.

This panel includes suggestions and commentaries on the following areas:

• Behavioral health
• Cardiology
• Gastroenterology
• Neurology
• Pain management
• Transplant
• Urology

The Pharmacogenomic panel delivers actionable analyses and recommendations around 44 different drug classes and 70 genes, providing insight into practical ways to support your patient’s medication selection to minimize side effects and maximize efficacy.